CVN Annual Scientific Conference (ASC) 2021 at ESCV 2021

Two sessions were run as part of the ESCV meeting on Friday September 17. Keynote lectures included: Screening for HTLV presented by Professor Graham Taylor Dengue virus vaccine and diagnostic challenges presented by Dr Peter Laing What’s new in congenital and post-natal CMV infection presented by Dr Seilesh Kadambari The lectures were recorded and can be accessed on the ESCV website

CVN Executive Committee 2021

Chair Mat Donati Joint Vice Chairs Catherine Moore and Stephen Winchester Secretary Husam Osman Treasurer Sowsan Atabani Scientific Affairs and Research Secretary Will Irving Meetings Secretary Stephen Winchester Website and Communications Secretary Mark Zuckerman Audit and Guidelines Secretary Alison Watt Clinical Scientists Representative Kelly Bicknell Biomedical Scientists Representative Jayne Harwood Medical Virology Representative Sophie Gillett Commercial Companies Representative Karen Jordan Coffey CVN Administrative Assistant Maggie Hopper

Clinical Virology Network Advisory Group

The UK CVN membership has key skills and experience to provide advice on the delivery of the UK COVID-19 pandemic response. In recognition of this, and in order to provide a representative view, the UK CVN executive agreed to form an advisory group comprising members across all regions and countries of the UK, and from the Republic of Ireland. At formation, the CVNAG will only consider topics related to SARS-CoV-2 and COVID-19. In due course, the group may widen the remit to cover other virological areas.

In the news